SMAD3 and Sepsis: The work conducted by Cao showed that miR-145 inhibited LPS-induced inflammation and sepsis-induced lung injury via directly targeting TGF-β2 and inactivating TGFBR2/ Smad3 signaling both in septic patients and mice [139].